Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome.
Avallone A, Aloj L, Caracò C, Delrio P, Pecori B, Tatangelo F, Scott N, Casaretti R, Di Gennaro F, Montano M, Silvestro L, Budillon A, Lastoria S. Avallone A, et al. Among authors: di gennaro f. Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1848-57. doi: 10.1007/s00259-012-2229-2. Epub 2012 Oct 5. Eur J Nucl Med Mol Imaging. 2012. PMID: 23053320 Clinical Trial.
Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma.
Aloj L, D'Ambrosio L, Aurilio M, Morisco A, Frigeri F, Caraco' C, Di Gennaro F, Capobianco G, Giovannoni L, Menssen HD, Neri D, Pinto A, Lastoria S. Aloj L, et al. Among authors: di gennaro f. Eur J Nucl Med Mol Imaging. 2014 May;41(5):867-77. doi: 10.1007/s00259-013-2658-6. Epub 2014 Jan 17. Eur J Nucl Med Mol Imaging. 2014. PMID: 24435772 Clinical Trial.
Targeted therapy: a new hope for thyroid carcinomas.
Perri F, Pezzullo L, Chiofalo MG, Lastoria S, Di Gennaro F, Scarpati GD, Caponigro F. Perri F, et al. Among authors: di gennaro f. Crit Rev Oncol Hematol. 2015 Apr;94(1):55-63. doi: 10.1016/j.critrevonc.2014.10.012. Epub 2014 Nov 1. Crit Rev Oncol Hematol. 2015. PMID: 25465739 Review.
Follicular thyroid carcinoma with skull metastases.
Chiofalo MG, Setola SV, Di Gennaro F, Fulciniti F, Catapano G, Losito NS, Sandomenico F, Catalano O, Pezzullo L. Chiofalo MG, et al. Among authors: di gennaro f. Endocr J. 2015;62(4):363-9. doi: 10.1507/endocrj.EJ14-0553. Epub 2015 Mar 20. Endocr J. 2015. PMID: 25797278 Free article.
18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer.
Avallone A, Aloj L, Pecori B, Caracò C, De Stefano A, Tatangelo F, Silvestro L, Granata V, Bianco F, Romano C, Di Gennaro F, Budillon A, Petrillo A, Muto P, Botti G, Delrio P, Lastoria S. Avallone A, et al. Among authors: di gennaro f. J Nucl Med. 2019 Nov;60(11):1560-1568. doi: 10.2967/jnumed.118.222604. Epub 2019 Mar 15. J Nucl Med. 2019. PMID: 30877175 Free PMC article. Clinical Trial.
Oligometastatic prostate cancer treatment.
Rossetti S, Di Napoli M, Pisano C, C Cecere S, Tambaro R, Ventriglia J, Passarelli A, Iovane G, Feroce F, Lastoria S, Di Gennaro F, Muto P, Borzillo V, Di Franco R, Perdonà S, Quarto G, Pignata S. Rossetti S, et al. Among authors: di gennaro f, di franco r, di napoli m. Future Oncol. 2021 Oct;17(29):3893-3899. doi: 10.2217/fon-2021-0126. Epub 2021 Jul 23. Future Oncol. 2021. PMID: 34296622
Analysis of Pros and Cons in Using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer.
Maisto C, Aurilio M, Morisco A, de Marino R, Buonanno Recchimuzzo MJ, Carideo L, D'Ambrosio L, Di Gennaro F, Esposito A, Gaballo P, Pirozzi Palmese V, Porfidia V, Raddi M, Rossi A, Squame E, Lastoria S. Maisto C, et al. Among authors: di gennaro f. Molecules. 2022 Jun 16;27(12):3862. doi: 10.3390/molecules27123862. Molecules. 2022. PMID: 35744985 Free PMC article.
A comparison of simplified protocols of personalized dosimetry in NEN patients treated by radioligand therapy (RLT) with [177Lu]Lu-DOTATATE to favor its use in clinical practice.
Pirozzi Palmese V, D'Ambrosio L, Di Gennaro F, Maisto C, de Marino R, Morisco A, Coluccia S, Di Gennaro P, De Lauro F, Raddi M, Gaballo P, Tafuto S, Celentano E, Lastoria S. Pirozzi Palmese V, et al. Among authors: di gennaro f, di gennaro p. Eur J Nucl Med Mol Imaging. 2023 May;50(6):1753-1764. doi: 10.1007/s00259-023-06112-8. Epub 2023 Jan 23. Eur J Nucl Med Mol Imaging. 2023. PMID: 36688980 Free PMC article.
182 results